CBIO
Crescent Biopharma
CBIO
CBIO
34 hedge funds and large institutions have $6.46M invested in Crescent Biopharma in 2025 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less capital invested
Capital invested by funds: $ → $
less funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
50% less first-time investments, than exits
New positions opened: 6 | Existing positions closed: 12
54% less call options, than puts
Call options by funds: $24K | Put options by funds: $52K
Holders
34
Holding in Top 10
–
Calls
$24K
Puts
$52K
Top Buyers
| 1 | +$80.3K | |
| 2 | +$74.9K | |
| 3 | +$49.8K | |
| 4 |
JFG
Jefferies Financial Group
New York
|
+$33.9K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$10.6K |
Top Sellers
| 1 | -$82.6K | |
| 2 | -$50.9K | |
| 3 | -$16K | |
| 4 |
Jane Street
New York
|
-$14.7K |
| 5 |
Renaissance Technologies
New York
|
-$10.2K |